StockData
Satellos Bioscience Inc. logo

Satellos Bioscience Inc. (MSLE) stock

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30
$6.20−0.27 (-4.17%)

Close on Nov 17, 2026Market cap $95.85MP/E –Yield –

Satellos Bioscience operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$23.60M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.60M–
FY2024Dec 31, 2024-$18.25M–

More Satellos Bioscience figures

See a number that looks wrong?